Emerald Health Therapeutics (TSXV:EMH; OTCQX:TBQBF) provided a corporate update to shareholders regarding recent developments and the company’s vision of growth for the future.
As quoted in the press release:
Emerald’s vision is to be a leading provider of cannabis products. As the eighth licensed producer in Canada, Emerald’s methodical approach to building its business has focused on its core competency: clinical research and the development of intellectual property for downstream cannabis products. The Company recently announced several substantial developments and is pursuing multiple opportunities to fulfill its strategy.
Rapidly and Cost Effectively Scaling Capacity
Emerald is undergoing two major expansion projects that will greatly increase production capacity, supporting the Company’s flower and extract production. These projects will enable us to produce high quality, low cost cannabis and provide the backbone for all of Emerald’s medical and adult-use endeavours.